Andrew P. Smith
Overview
Andrew P. Smith received an average of $1M in total compensation, including $333K in salary, at Sucampo Pharmaceuticals from 2014 to 2016.
Source: SEC filing on April 21, 2017.
Related executives
We found six more executives who work or worked at Sucampo Pharmaceuticals.
Peter Greenleaf
Sucampo Pharmaceuticals
Chief Executive Officer
Peter Kiener
Sucampo Pharmaceuticals
Chief Scientific Officer
Max Donley
Sucampo Pharmaceuticals
EVP, Global Human Resources, Information Technology and Strategy
Matthias Alder
Sucampo Pharmaceuticals
General Counsel
Thomas Knapp
Sucampo Pharmaceuticals
Chief Legal Officer
Peter Lichtlen
Sucampo Pharmaceuticals